YS Biopharma Co Ltd - Warrants (15/03/2028

(Warrants)
NAS:YSBPW (China)   Warrants (15/03/2028)
$ 0.09 +0.0097 (+12.11%) 02:58 PM EST
At Loss
P/B:
0.90
Volume:
500.00
Avg Vol (2M):
-
Also Trade In:
Volume:
500.00
At Loss
Avg Vol (2M):
-

Business Description

Description
YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.
Name Current Vs Industry Vs History
Cash-To-Debt 0.47
Equity-to-Asset 0.35
Debt-to-Equity 1
Debt-to-EBITDA -2.26
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.5
Distress
Grey
Safe
Beneish M-Score -2.19
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.41
Quick Ratio 1.09
Cash Ratio 0.39
Days Inventory 608.72
Days Sales Outstanding 296.23
Days Payable 220.45

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -8.12
Name Current Vs Industry Vs History
Gross Margin % 80.03
Operating Margin % -50.8
Net Margin % -54.84
ROE % -279.39
ROA % -18.85
ROIC % -29.43
ROC (Joel Greenblatt) % -35.11
ROCE % -27.78

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 0.87
PB Ratio 0.9
EV-to-EBIT -4.59
EV-to-EBITDA -5.35
EV-to-Revenue 2.27
EV-to-FCF -4.53
Earnings Yield (Greenblatt) % -21.79
FCF Yield % -28.52

Financials (Next Earnings Date:2024-08-15 Est.)

YSBPW's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:YSBPW

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

YS Biopharma Co Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) 0
Beta 0
Volatility % 0
14-Day RSI 0
14-Day ATR ($) 0
20-Day SMA ($) 0
12-1 Month Momentum % 0
52-Week Range ($) 0 - 0.2033
Shares Outstanding (Mil)

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

YS Biopharma Co Ltd Filings

Filing Date Document Date Form
No Filing Data

YS Biopharma Co Ltd Stock Events

Financials Calendars
Event Date Price($)
No Event Data

YS Biopharma Co Ltd Frequently Asked Questions

What is YS Biopharma Co Ltd(YSBPW)'s stock price today?
The current price of YSBPW is $0.09. The 52 week high of YSBPW is $0.20 and 52 week low is $0.00.
When is next earnings date of YS Biopharma Co Ltd(YSBPW)?
The next earnings date of YS Biopharma Co Ltd(YSBPW) is 2024-08-15 Est..
Does YS Biopharma Co Ltd(YSBPW) pay dividends? If so, how much?
YS Biopharma Co Ltd(YSBPW) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1